Fuchs' Endothelial Dystrophy Clinical Trial
— TREKOfficial title:
Technique And Results Evaluation In Endothelial Keratoplasty
NCT number | NCT02470793 |
Other study ID # | 00001 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | September 2014 |
Est. completion date | January 2021 |
Verified date | March 2021 |
Source | Hospital Mutua de Terrassa |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
To assess and compare the complications and results of different lamellar endothelial keratoplasty techniques and its variations.
Status | Completed |
Enrollment | 62 |
Est. completion date | January 2021 |
Est. primary completion date | January 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: 1. Diagnosis with corneal endothelial dysfunction requiring lamellar endothelial corneal transplantation. 2. Free acceptance to be enrolled in the trial, and signature of the informed consent by the subject and/or its legal representatives. Exclusion Criteria: N/A |
Country | Name | City | State |
---|---|---|---|
Spain | Hospital Universitari Mutua Terrassa | Terrassa | Barcelona |
Lead Sponsor | Collaborator |
---|---|
EDUARD PEDEMONTE-SARRIAS |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Visual acuity | First six months postoperatively | ||
Secondary | Endothelial cell density | First six months postoperatively | ||
Secondary | Intraoperative complications | First six months postoperatively | ||
Secondary | Postoperative complications | First six months postoperatively |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03248037 -
Trial of Netarsudil for Prevention of Corticosteroid-induced Intraocular Pressure Elevation
|
Phase 3 | |
Recruiting |
NCT03275896 -
Evaluation of the Efficacy of Descemet Membrane Transplantation for the Treatment of Fuchs' Endothelial Dystrophy
|
Early Phase 1 | |
Completed |
NCT02332109 -
ODM 5 in the Treatment of Corneal Edematous Fuchs' Endothelial Dystrophy
|
N/A | |
Recruiting |
NCT01206127 -
DSAEK- Postoperative Positioning and Transplant Dislocation
|
N/A | |
Recruiting |
NCT03407755 -
Air Versus SF6 for Descemet's Membrane Endothelial Keratoplasty (DMEK)
|
N/A | |
Completed |
NCT04140422 -
Eye Drops for Early Morning-Associated Corneal Swelling of the Cornea
|
N/A | |
Recruiting |
NCT06048380 -
The Effects of Ripasudil in Patients With FED Undergoing Femtosecond Laser Assisted Cataract Surgery
|
Phase 3 | |
Completed |
NCT02793310 -
DMEK Versus DSAEK Study
|
N/A | |
Completed |
NCT01795001 -
The Molecular Pathogenesis of Late-onset Fuchs' Endothelial Corneal Dystrophy
|
||
Completed |
NCT04057053 -
Netarsudil Use After Descemetorhexis Without Endothelial Keratoplasty
|
Early Phase 1 | |
Terminated |
NCT01361282 -
Using the Optovue OCT to Select IOL Power
|
N/A | |
Completed |
NCT02542644 -
Assessment of Corneal Graft Attachment in Patients With Fuchs Endothelial Corneal Dystrophy Following DMEK Using Ultra-high Resolution OCT
|
N/A | |
Recruiting |
NCT04191629 -
Phase 1 Study to Evaluate the Safety and Tolerability of EO1404 in the Treatment of Corneal Edema
|
Phase 1 | |
Completed |
NCT05399095 -
Supine Positioning for Graft Attachment After Descemet Membrane Endothelial Keratoplasty
|
N/A | |
Completed |
NCT04752020 -
Netarsudil Use After Descemtorhexis Without Endothelial Keratoplasty
|
Early Phase 1 | |
Not yet recruiting |
NCT05716945 -
The OPTIMISE Study
|
Phase 4 | |
Recruiting |
NCT03575130 -
Ripasudil 0.4% Eye Drops in Fuchs Endothelial Corneal Dystrophy
|
Phase 2 | |
Recruiting |
NCT02118922 -
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
|
||
Completed |
NCT04420429 -
The Effect Of Preoperative Parameters On Success After DMEK Surgery
|
||
Withdrawn |
NCT04018417 -
Evaluation of Amphotericin B in Optisol-GS for Prevention of Post-Keratoplasty Fungal Infections.
|
Phase 2/Phase 3 |